Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Undifferentiated pelvic adenocarcinomas: diagnostic potential of protein profiling and multivariate analysis.

Roblick UJ, Bader FG, Lenander C, Hellman U, Zimmermann K, Becker S, Ost A, Alaiya A, Bruch HP, Keller R, Mirow L, Franzén B, Ried T, Auer G, Habermann JK.

Int J Colorectal Dis. 2008 May;23(5):483-91. doi: 10.1007/s00384-008-0448-6. Epub 2008 Feb 22.

PMID:
18293003
2.
3.

Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma.

Torenbeek R, Lagendijk JH, Van Diest PJ, Bril H, van de Molengraft FJ, Meijer CJ.

Histopathology. 1998 Jan;32(1):20-7.

PMID:
9522212
4.

SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.

Moh M, Krings G, Ates D, Aysal A, Kim GE, Rabban JT.

Am J Surg Pathol. 2016 Mar;40(3):419-32. doi: 10.1097/PAS.0000000000000553.

PMID:
26551622
5.

Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement.

Judson K, McCormick C, Vang R, Yemelyanova AV, Wu LS, Bristow RE, Ronnett BM.

Int J Gynecol Pathol. 2008 Apr;27(2):182-90. doi: 10.1097/PGP.0b013e31815b9752.

PMID:
18317225
6.

The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.

Sheridan T, Herawi M, Epstein JI, Illei PB.

Am J Surg Pathol. 2007 Sep;31(9):1351-5.

PMID:
17721190
7.

NKX3.1 as a marker of prostatic origin in metastatic tumors.

Gurel B, Ali TZ, Montgomery EA, Begum S, Hicks J, Goggins M, Eberhart CG, Clark DP, Bieberich CJ, Epstein JI, De Marzo AM.

Am J Surg Pathol. 2010 Aug;34(8):1097-105. doi: 10.1097/PAS.0b013e3181e6cbf3.

8.

Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma.

Park SY, Kim BH, Kim JH, Lee S, Kang GH.

Arch Pathol Lab Med. 2007 Oct;131(10):1561-7.

PMID:
17922593
10.

Identification from public data of molecular markers of adenocarcinoma characteristic of the site of origin.

Dennis JL, Vass JK, Wit EC, Keith WN, Oien KA.

Cancer Res. 2002 Nov 1;62(21):5999-6005.

11.

Monoclonal antibody SM047 as an immunohistochemical marker of ovarian adenocarcinoma.

McCluggage WG, Maxwell P, Veenstra H, Fick CE, Laeng RH, Tiltman AJ.

Histopathology. 2001 Jun;38(6):542-9.

PMID:
11422498
12.

Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles.

Giordano TJ, Shedden KA, Schwartz DR, Kuick R, Taylor JM, Lee N, Misek DE, Greenson JK, Kardia SL, Beer DG, Rennert G, Cho KR, Gruber SB, Fearon ER, Hanash S.

Am J Pathol. 2001 Oct;159(4):1231-8.

14.

Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm.

Dennis JL, Hvidsten TR, Wit EC, Komorowski J, Bell AK, Downie I, Mooney J, Verbeke C, Bellamy C, Keith WN, Oien KA.

Clin Cancer Res. 2005 May 15;11(10):3766-72.

15.

p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.

Vang R, Gown AM, Farinola M, Barry TS, Wheeler DT, Yemelyanova A, Seidman JD, Judson K, Ronnett BM.

Am J Surg Pathol. 2007 May;31(5):653-63.

PMID:
17460447
16.

Metastatic adenocarcinoma of unknown primary origin.

Hammar SP.

Hum Pathol. 1998 Dec;29(12):1393-402. Review.

PMID:
9865824
17.

CDX-2 immunostaining in primary and secondary ovarian carcinomas.

Tornillo L, Moch H, Diener PA, Lugli A, Singer G.

J Clin Pathol. 2004 Jun;57(6):641-3.

18.

Is immunostaining with HAM56 antibody useful in identifying ovarian origin of metastatic adenocarcinomas?

Cheung AN, Chiu PM, Khoo US.

Hum Pathol. 1997 Jan;28(1):91-4. Review.

PMID:
9013838
19.

The role of L1-CAM immunohistochemial staining in the diagnosis of abdominal-pelvic cancer of uncertain primary site in women.

Ben-Arie A, Huszar M, Ben-Zvi N, Smirnov A, Altevogt P, Fogel M.

Eur J Surg Oncol. 2008 Jul;34(7):795-9. Epub 2007 Sep 12.

PMID:
17845837
20.

[Krukenberg syndrome in metastatic gallbladder adenocarcinoma with unknown primary tumor].

Unterweger M, Caduff R, Bajka M, Klotz HP, Kubik-Huch RA.

Praxis (Bern 1994). 1999 Aug 12;88(33):1320-3. German.

PMID:
10483284

Supplemental Content

Support Center